Manufacture

From improving solubility and bioavailability to making formulations suitable for inhalation – micronization is a versatile technique.

Viral vector manufacture has come a long way, but the story is far from over.

PCI has focused on becoming a trusted CDMO partner by building strong working relationships with clients.

Cytiva is transforming in the wake of COVID-19 – but what lessons can the wider biopharma industry take forward?

What happened in April in the biopharma industry? Here’s our roundup of the biggest headlines and research.

How can multi-column chromatography support companies as they set their sights on intensified bioprocesses?

Is commercializing gene therapy manufacturing an unsolvable problem? We ask an expert on the frontlines.

Driven by the success of COVID-19 vaccines, mRNA products are expanding drug developers’ pipelines.

Overcoming supply chain woes will require digital intervention.

With the FDA still behind on inspections, manufacturers need to uncover their own blindspots.